News Focus
News Focus
Followers 177
Posts 16252
Boards Moderated 1
Alias Born 01/26/2016

Re: exwannabe post# 630906

Thursday, 09/14/2023 1:02:20 PM

Thursday, September 14, 2023 1:02:20 PM

Post# of 823759
exwannabe,

The issue is that any other ATL DC would need to prove itself safe and effective for the indication being applied for. Safe is one thing, effective due to proper cell activation/maturation is quite another. There is a reason why L works better and it’s in the way it is made. NWBO is not giving away the exact recipe in its patents so others will not be able to compete once L is approved for other indications. That is the main reason why they are not pursuing their own version. NWBO is too far ahead and their work would end up being wasted time and money; ). Best wishes.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News